SequelSEC

BIO KEY INTERNATIONAL INC BKYI

Services-Prepackaged Software · CIK 0001019034 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$6.70M
Fiscal year ended 2026-06-30
Operating income
-$5.79M
Fiscal year ended 2026-06-30
Free cash flow
-$4.16M
Fiscal year ended 2026-06-30

Valuation, from the filing

Public float$4.93MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$4.55Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue0.8×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity1.0×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Services-Prepackaged Software filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
FCF margin-78.8%9th
CapEx / revenue0.2%12th
Revenue YoY growth-14.3%13th
Operating margin-115.0%16th
Net margin-120.6%17th
R&D / revenue44.0%82th
Gross margin76.9%67th
Current ratio1.47x50th

BIO KEY INTERNATIONAL INC (BKYI) reported revenue of $6.70M and net income of -$6.04M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from BIO KEY INTERNATIONAL INC’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Prepackaged Software.

Income

BIO KEY INTERNATIONAL INC income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$6.70M
Cost of revenue$1.25M
Gross profit$5.45M
Operating income-$5.79M
Net income-$6.04M
Research & development$2.64M
Weighted-average diluted sharesUnavailable
Pretax income-$6.02M
Income tax expense$16.50K
Diluted EPSUnavailable
Selling, general & administrative$6.10M
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

BIO KEY INTERNATIONAL INC balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$1.38M
Total assets$7.48M
Current assets$3.81M
Total liabilities$3.15M
Current liabilities$3.01M
Total equity incl. NCI$4.33M
Temporary (mezzanine) equityUnavailable
Inventory$375.74K
Accounts receivable$1.73M
GoodwillUnavailable
Long-term debtUnavailable
Accounts payable$411.20K

Cash flow

BIO KEY INTERNATIONAL INC cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow-$4.16M
Capital expenditures$5.96K
Investing cash flow-$5.96K
Financing cash flow$3.39M
Net change in cash-$896.04K
Stock-based compensationUnavailable
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortizationUnavailable

Derived

BIO KEY INTERNATIONAL INC derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flow-$4.16M
Gross margin81.3%
Operating margin-86.4%
FCF margin-62.1%
SBC / revenueUnavailable
Current ratio1.26x
Revenue YoY growth-3.1%
Net margin-90.1%
R&D / revenue39.3%
CapEx / revenue0.1%
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open BKYI in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-13View SEC filing
10-Q · Filed 2026-06-22View SEC filing
10-K · Filed 2026-06-12View SEC filing
10-Q · Filed 2025-11-14View SEC filing
10-Q · Filed 2025-08-13View SEC filing
10-Q · Filed 2025-05-15View SEC filing

Companies in the same industry

ACIW ADBE ADSK AEYE AI AIFF AISP AITX ALKT ALRM ALSAF AMPL

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.